Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DR REDDYS LABORATORIES LTD Regulatory Filings 2021

Oct 29, 2021

30528_rns_2021-10-29_385c1726-9c59-4f75-876b-ec14fbcfc32f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

••• Dr.Reddy's �;•

Dr. Raddy"s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507

Tel :+9140 4900 2900 Fax :+91 40 4900 2999 Email :[email protected] www.drreddys.com

October 29, 2021

To, The Secretary BSE Limited National Stock Exchange oflndia Ltd. New York Stock Exchange Inc. NSE IFSC Limited

Dear Sir/ Madam,

Sub: Intimation

This is to inform you that the audit of our formulations manufacturing facilities (FTO 7 & FTO 9) at Duwada, Visakhapatnam, by the US FDA, has been completed today. We have been issued a Form 483 with 8 (eight) observations, which we will address within the stipulated timeline.

This is for your information.

Yours faithfully, For Dr. Reddy's Laboratories Limited

==> picture [134 x 80] intentionally omitted <==